Immunosuppressant‐responsive enteropathy and non‐responsive enteropathy in dogs: Prognostic factors, short‐ and long‐term follow up

Abstract

A multicentre prospective study was performed to assess whether clinical, hematobio-chemical, endoscopic and histopathological parameters were associated with mortality, clinical response and relapse of disease in short‐ and long‐term follow‐up of a total of 165 dogs with chronic inflammatory enteropathy, of which 150 had immunosuppressant responsive enteropathy (IRE), and 15 had non‐responsive enteropathy (NRE) dogs. Clinical severity (CCECAI) was evaluated from presentation (T0) to 18 months (T18) from diagnosis. T0 body condition score (BCS), selected haematological parameters and endoscopic and histopathological scores were evaluated. Pres-ence/absence of histopathological duodenal lesions was recorded. Responders were evaluated using CCECAI at T1. Relapse was evaluated from T3 to T18. Long‐term responders included dogs who responded at T1 and showed no relapse. Dogs were divided into responders/non‐responders, survivors/non‐survivors and relapsed/non‐relapsed. At T1, 15/165 dogs (9%) were considered NRE. Sixteen dogs (11%) were considered relapsed at T3, 8% at T6 and 10% at T12, and none of 96 dogs relapsed at T18. NREs showed significantly lower BCS than IREs. Non‐survivors showed a significantly lower serum albumin concentration and BCS than survivors. Non‐responders, relapsed or non‐survivors had higher presence of lacteal dilatation compared to long‐term responders. Dogs with IRE showed a good clinical course with a low relapse rate, with only a few dogs in the NRE group. Reduction of BCS, albumin and lacteal dilatation at diagnosis may be considered negative prognostic factors for response, mortality and long‐term disease remission.